Uterine leiomyoma: understanding the impact of symptoms on womens’ lives

dc.contributor.authorBrito, Luiz Gustavo Oliveira
dc.contributor.authorPanobianco, Marislei Sanches
dc.contributor.authorSabino-de-Freitas, Maurício Mesquita
dc.contributor.authorBarbosa, Hermes de Freitas
dc.contributor.authorAzevedo, George Dantas de
dc.contributor.authorBrito, Luciane Maria Oliveira
dc.contributor.authorCandido-dos-Reis, Francisco José
dc.date.accessioned2021-02-22T18:29:14Z
dc.date.available2021-02-22T18:29:14Z
dc.date.issued2014-01-30
dc.description.resumoBackground: most women report negative experience about the symptoms of uterine leiomyoma (UL) in their lives, such as abnormal uterine bleeding and pelvic pain. Many studies have been conducted about efficacy of UL treatment, but little research has been performed about womens health related quality of life (HRQL). Methods: this is a semi-structured, descriptive, observational, qualitative study that was performed during eight months. Focus group (FG) interviews were performed with women attending at a tertiary hospital in Brazil, who were consecutively included in the study. Seventy women with symptomatic UL were recruited to this study. FG duration was one hour with mediators with 5-6 women at each group. Collected data from discussions was processed according to thematic analysis and stored at a qualitative software. Results: women were negatively influenced by the presence of symptomatic UL. The major themes that were noticed during analysis were: beliefs and attitudes towards UL; limitation to social and professional activities; sensation of fear/unfairness/discouragement towards the symptoms and adverse effects during treatment with GnRH analogs. Conclusions: symptomatic UL has a negative impact on womens HRQL. Health providers should consider such impact when counseling women on their treatment options, since it may have an important influence in these patients’ decision-making process. While current pharmacological treatments may improve disease specific outcomes, such as bleeding intensity and tumor volume, they fail on actually improving quality of lifept_BR
dc.identifier.citationBRITO, Luiz Gustavo Oliveira; PANOBIANCO, Marislei Sanches; SABINO-DE-FREITAS, Maurício Mesquita; BARBOSA, Hermes de Freitas; AZEVEDO, George Dantas de; BRITO, Luciane Maria Oliveira; CANDIDO-DOS-REIS, Francisco José. Uterine leiomyoma: understanding the impact of symptoms on womens' lives. Reproductive Health, [s. l.], v. 11, n. 1, p. 1-5, jan. 2014. Disponível em: https://reproductive-health-journal.biomedcentral.com/articles/10.1186/1742-4755-11-10. Acesso em: 30 jun. 2020. http://dx.doi.org/10.1186/1742-4755-11-10pt_BR
dc.identifier.doi10.1186/1742-4755-11-10
dc.identifier.issn1742-4755
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/31599
dc.languageenpt_BR
dc.publisherBMCpt_BR
dc.rightsAttribution 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/br/*
dc.subjectUterine leiomyomapt_BR
dc.subjectHealth related quality of lifept_BR
dc.subjectCounselingpt_BR
dc.subjectQualitative researchpt_BR
dc.subjectAbnormal uterine bleedingpt_BR
dc.subjectPelvic painpt_BR
dc.titleUterine leiomyoma: understanding the impact of symptoms on womens’ livespt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
UterineLeiomyomaSymptoms_Azevedo_2014.pdf
Tamanho:
236.53 KB
Formato:
Adobe Portable Document Format
Carregando...
Imagem de Miniatura
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar